Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Scot Remick

Developing Research Capacity for Aids Malignancy in Kenya

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Pediatric oncology or childhood cancer

Eduardo Sotomayor

Research in Transformed and Aggressive B-cell lymphomas; Personalized Medicine Initiatives

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Michael Wang

A Phase II, Multicenter, International Study of Lenalidomide and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Non-Hodgkin Lymphoma, Transformed Large Cell Lymphoma, and Grade 3 Follicular Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Colorectum

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Jean William Pape

Global Health Research and Training in HIV and Tuberculosis

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri